Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05715463 · ClinicalTrials.gov registry record · NA

Rheumatology-based Adaptive Intervention for Social Determinants and Health Equity

A NA study of Rheumatoid Arthritis and Psoriatic Arthritis, sponsored by Brigham and Women's Hospital.

Active
Registry status
NA
Development phase
101
Enrollment target
1
Study location

NCT05715463 is a NA study of Rheumatoid Arthritis and Psoriatic Arthritis that is active but no longer recruiting, run by Brigham and Women's Hospital. The registered enrollment target is 101 participants, below the 4,690-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05715463, a NA study of Rheumatoid Arthritis and Psoriatic Arthritis, is active but no longer recruiting, sponsored by Brigham and Women's Hospital.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
101 participants
Enrollment target
1
Study location

Study Summary

Social determinants of health (SDoH), defined by the World Health Organization as "the conditions in which people are born, grow, work, live and age and the wider set of forces and systems shaping the conditions of daily life" are estimated to be responsible for nearly 90 percent of a person's health outcomes. SDoH are key contributors to racial, ethnic and socioeconomic disparities in care healthcare access and health outcomes. The goal of this clinical trial is to identify patients with inflammatory arthritis or with a systemic rheumatic condition with arthritis who may respond to the simplest and least expensive intervention to address their SDoH-related needs- a tailored list of resources, those who benefit from a community-based resource specialist to help address specific needs, and those who require a nurse-trained navigator to help both coordinate the services provided by the community-based specialist, and their medical and mental health care and needs. The main questions the clinical trial aims to answer are: 1. To test the efficacy of a rheumatology clinic-based nurse navigator and community resource specialist to reduce appointment no-shows and same-day cancellations in patients with systemic rheumatic conditions with arthritis. 2. To examine the cost-effectiveness of each of the different study interventions for individuals with systemic rheumatic conditions with arthritis with SDoH-related needs using questionnaires and cost-related care metrics. Participants will be randomly assigned to 1 of 3 arms. In Arm 1, patients will receive a cultivated list of resources related to the needs that patients indicate on the social determinants of health questionnaire. Arm 1 is the control arm which receives the current standard of care. In Arm 2, patients will receive the assistance of a community resource specialist (CRS) - an individual without formal medical training with community-based expertise. In Arm 3, patients will receive the assistance of a nurse pat

Interventions

  • OTHER Nurse Navigator
  • OTHER Resource sheets
  • OTHER Community Resource Specialist

Study Locations (1)

Massachusetts

  • Brigham & Women's Hospital - Boston

Trial Details

FieldValue
Enrollment Target 101 participants
Start Date 2023-03-01
Est. Completion 2026-12-01
Phase NA

Sponsor

Brigham and Women's Hospital

937 total trials

What the Registry Record Tells You About NCT05715463

The ClinicalTrials.gov registry entry for NCT05715463 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 101 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,690-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (98% lower). The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.

The record links to 10 conditions, with Rheumatoid Arthritis appearing as the primary indexed condition, and to 3 interventions - of which Nurse Navigator is the first listed.

NCT05715463 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT05715463 about?

NCT05715463 is a clinical study titled "Rheumatology-based Adaptive Intervention for Social Determinants and Health Equity". Social determinants of health (SDoH), defined by the World Health Organization as "the conditions in which people are born, grow, work, live and age and the wider set of forces and systems shaping the conditions of daily life" are estimated to be responsible for nearly 90 percent of a person's healt...

What is the current status of trial NCT05715463?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 101 participants. The study started on 2023-03-01. Estimated completion is 2026-12-01.

What conditions does trial NCT05715463 study?

This clinical trial studies the following conditions: Rheumatoid Arthritis, Psoriatic Arthritis, Systemic Sclerosis, Ankylosing Spondylitis, Lupus.

What interventions are being tested in trial NCT05715463?

The interventions under investigation include: Nurse Navigator (OTHER), Resource sheets (OTHER), Community Resource Specialist (OTHER).

Who is sponsoring clinical trial NCT05715463?

This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05715463 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Rheumatoid Arthritis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.